earnings
confidence high
sentiment negative
materiality 0.85
CVS Health Q1 GAAP EPS $0.88 vs $1.65; FY2024 guidance slashed on Medicare pressure
CVS HEALTH Corp
2024-Q1 EPS reported
$0.88
revenue$88,437,000,000
- Q1 revenues rose 3.7% to $88.4B; GAAP diluted EPS $0.88 vs $1.65; adjusted EPS $1.31 vs $2.20.
- Operating income fell to $2.3B from $3.4B; Health Care Benefits segment pressured by Medicare utilization.
- FY2024 guidance cut: GAAP EPS at least $5.64 (from $7.06); Adj EPS at least $7.00 (from $8.30).
- Q1 cash flow from operations $4.9B; FY guidance reduced to at least $10.5B from $12.0B.
- CEO cites Medicare Advantage challenges; expects elevated cost trends to persist through 2024.